Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study investigated the relationship of obesity, insulin resistance, inflammation and angiogenesis with cancer progression and survival in a colorectal cancer cohort. METHODS: Clinical and pathological data, along with anthropometric and follow-up data, were collected from 344 consecutive colorectal cancer patients. Serum samples at diagnosis were analysed by immunoassay for adiponectin, C-reactive protein (CRP), vascular endothelial growth factor-A (VEGF-A), angiopoietin-2 (Ang-2), insulin-like growth factor-1 (IGF-1), insulin and C-peptide. RESULTS: Serum Ang-2 and VEGF-A levels increased with tumour T stage (P=0.007 and P=0.025, respectively) and N stage (P=0.02 and P=0.03, respectively), and correlated with CRP levels (r=0.43, P<0.001 and r=0.23, P<0.001, respectively). Angiopoietin-2 correlated with C-peptide (r=0.14, P=0.007) and VEGF-A with IGF-1 in males (r=0.25, P=0.001). Kaplan-Meier analysis showed that patients with high serum levels of CRP and Ang-2 had significantly reduced survival (both P≤0.001). After adjusting for tumour stage and age, Ang-2 remained a significant predictor of survival. The CRP levels were inversely associated with survival in American Joint Committee on Cancer stage II patients (P=0.038), suggesting that CRP could be used to support treatment decisions in this subgroup. Serum markers and anthropometric measures of obesity correlated with each other, but not with survival. CONCLUSION: Our study supports the concept that obesity-related inflammation, rather than obesity itself, is associated with colorectal cancer progression and survival. The study confirms serum Ang-2 as a predictive marker for outcome of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196 · cited 2×
“This association is supported by in vitro data (Bello et al, 2008; Turu et al, 2008; Porta et al, 2009) and recent data from an Ang-2 knock-out mouse model, where lack of Ang-2 reduced inflammatory bowel disease (Ganta et al, 2010).”
BackgroundResult(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Experimental and epidemiological studies support the concept that chronic inflammation has cancer-promoting properties (Mantovani et al, 2008; Porta et al, 2009).”
BackgroundAmerican Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824 · cited 1×
“While total serum levels of adiponectin and IGF-1 were measured, our assay system was unable to distinguish high molecular weight multimers of adiponectin, which represent the most biologically active form (Kadowaki et al, 2006), and may have better predictive value.”
MethodInflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170 · cited 1×
“It is now well established that obesity is characterised by chronic inflammation (Greenberg and Obin, 2006; Park et al, 2010), with associated increases of CRP, interleukin-6 (IL-6) and plasminogen activator inhibitor (Dandona et al, 2004).”
BackgroundPark, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · cited 2×
“Recent in vivo data in dietary and genetically obese mouse models demonstrated obesityrelated liver inflammation and subsequent release of IL-6 and TNFa (Park et al, 2010).”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 3×
“…of obesity and metabolic syndrome as risk factors for colorectal cancer development, data are equivocal for their effects on colorectal cancer progression and outcome (Trevisan et al, 2001; Dignam et al, 2006; Reeves et al, 2007; Meyerhardt et al, 2008; Moon et al, 2008; Wolpin et al, 2009).”
BackgroundResultInfluential
Research works printed but not linked: 1
- Ministry of Health (2007) Diabetes surveillance: population-based estimates and projections for New Zealand, 2001–2011: Public Health Intelligence Occasional Bulletin No. 46. Ministry of Health: Wellington. http://www.moh.govt.nz/moh.nsf/indexmh/diabetes-suveillance-population-estimates-projections-2001-2011, accessed 21 April 2010
Cited by
Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., & Lorton, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143080 · Cited by 274
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197
Microparticles in Angiogenesis: Therapeutic Potential
Martinez, M. C., & Andriantsitohaina, R. (2011) · Circulation Research · doi:10.1161/circresaha.110.233049 · Cited by 178
Obesity and colorectal cancer: molecular features of adipose tissue
Martinez-Useros, J., & Garcia-Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 167
Wei, X.-L., Wang, F.-H., Zhang, D.-S., Qiu, M.-Z., Ren, C., Jin, Y., Zhou, Y.-X., Wang, D.-S., He, M.-M., Bai, L., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1379-6 · Cited by 159
“Inflammatory factors derive not only from the systemic reaction to malignancies, but also the secretion of tumor cells, including acute phase proteins like CRP, [18,19] chemokines [20], cytokines like interleukin 6 (IL-6) [21], transcription factor like NF-κB [22], circulating and infiltration immune cells [23] and so…”
BackgroundInfluentialC-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis
Zhou, B., Shu, B., Yang, J., Liu, J., Xi, T., & Xing, Y. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0445-8 · Cited by 156
The Role of Chronic Inflammation in Obesity-Associated Cancers
Ramos-Nino, M. E. (2013) · ISRN Oncology · doi:10.1155/2013/697521 · Cited by 127
Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia
Stadlmayr, A., Aigner, E., Steger, B., Scharinger, L., Lederer, D., Mayr, A., Strasser, M., Brunner, E., Heuberger, A., Hohla, F., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02377.x · Cited by 126
Recreational physical activity, body mass index, and survival in women with colorectal cancer
Kuiper, J. G., Phipps, A. I., Neuhouser, M. L., Chlebowski, R. T., Thomson, C. A., Irwin, M. L., Lane, D. S., Wactawski-Wende, J., Hou, L., Jackson, R. D., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0071-2 · Cited by 124
Lee, D. H., Kim, J. Y., Lee, M. K., Lee, C., Min, J.-H., Jeong, D. H., Lee, J.-W., Chu, S. H., Meyerhardt, J. A., Ligibel, J., et al. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1822-7 · Cited by 95
“Studies have shown that insulin resistance, C-peptide, insulin growth factor (IGF)-1, IGF binding protein (IGFBP)-1 and -3, and some cytokines have been proposed as factors that may influence the prognosis of colorectal cancer patients [10, 35, 38, 40, 42].”
BackgroundWu, S., Liu, J., Wang, X., Li, M., Gan, Y., & Tang, Y. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0450-y · Cited by 93
“The result was consistent when the data sets from Asia, Europe, or Oceania were analyzed separately.”
BackgroundInfluentialPeeters, M., Strickland, A. H., Lichinitser, M., Suresh, A. V. S., Manikhas, G., Shapiro, J., Rogowski, W., Huang, X., Wu, B., Warner, D., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.594 · Cited by 79
“Elevated serum angiopoietin-2 has been reported in patients with colorectal cancer compared with healthy controls (Goede et al, 2010), and increased serum angiopoietin-2 has been associated with poorer survival outcomes (Volkova et al, 2011).”
BackgroundExcess adiposity and survival in patients with colorectal cancer: a systematic review
Parkin, E., O'Reilly, D. A., Sherlock, D., Manoharan, P., & Renehan, A. G. (2014) · Obesity Reviews · doi:10.1111/obr.12140 · Cited by 82
“Only two studies (55,56) examined survival across categories of BMI using the recognized WHO range for ‘normal’ weight as a reference; the other papers either dichotomized BMI into < or ≥30 kg m−2 (47,48,50); applied a cut-off value of 25 kg m−2 (51,53) or used the WHO BMI criteria for Asian populations (52).”
MethodThe role of tumor angiogenesis as a therapeutic target in colorectal cancer
Battaglin, F., Puccini, A., Intini, R., Schirripa, M., Ferro, A., Bergamo, F., Lonardi, S., Zagonel, V., Lenz, H., & Loupakis, F. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1428092 · Cited by 84
“Higher expression of Ang-2 has been associated with metastatic growth and poorer survival outcomes in CRC [9].”
BackgroundNF-κB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets
Bahrami, A., Khalaji, A., Najafi, M. B., Sadati, S., Raisi, A., Abolhassani, A., Eshraghi, R., Mahabady, M. K., Rahimian, N., & Mirzaei, H. (2024) · European journal of medical research · doi:10.1186/s40001-024-02168-w · Cited by 79
Lee, J. Y., Sim, T.-B., Lee, J., & Na, H. (2017) · Clinical Nutrition Research · doi:10.7762/cnr.2017.6.3.147 · Cited by 71
“Obese patients with colon cancer show the markedly elevated levels of serum C-reactive protein, which is correlated with poor prognosis [29].”
BackgroundCirculating Angiopoietin-2, Its Soluble Receptor Tie-2, and Mortality in the General Population
Lorbeer, R., Baumeister, S. E., Dörr, M., Nauck, M., Grotevendt, A., Völzke, H., Vasan, R. S., Wallaschofski, H., & Lieb, W. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft117 · Cited by 62
“23 per 1 unit increment in Ang-2 levels.(23) In our population-based sample, in contrast, we did not observe a consistent association of Ang-2 with cancer mortality in the general population, although we observed a statistically nonsignificant positive trend towards greater cancer mortality with higher Ang-2 levels.”
ResultHacker, U. T., Escalona-Espinosa, L., Consalvo, N., Goede, V., Schiffmann, L. M., Scherer, S. J., Hedge, P., Cutsem, E. V., Coutelle, O., & Büning, H. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.30 · Cited by 64
“…Ang-2 has previously been shown to be a prognostic biomarker of survival in other solid tumour entities, such as colorectal cancer, hepatocellular carcinoma, non-small cell lung cancer and melanoma (Park et al, 2007; Helfrich et al, 2009; Goede et al, 2010; Volkova et al, 2011; Llovet et al, 2012).”
BackgroundLee, J., Park, Y., Yun, J., Ahn, Y., Lee, K., Kim, D. B., Lee, J. M., Han, K., & Ko, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226351 · Cited by 62
Bendell, J. C., Saurí, T., Gracián, A. C., Álvarez-Gallego, R., López, C., Alfonso, P. G., Hussein, M., Mirón, M. L. L., Cervantes, A. M. R., Montagut, C. O., et al. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0291 · Cited by 49
“High serum Ang-2 levels promote metastatic growth in preclinical models [5] and are associated with poor survival outcomes in patients [6].”
BackgroundGraham, S. M., Rajwans, N., Tapia, K. A., Jaoko, W. G., Estambale, B. B. A., McClelland, R. S., Overbaugh, J. M., & Liles, W. C. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-263 · Cited by 41
“However, estrogen stimulates ANG-2 mRNA expression and inhibits ANG-1 expression in non-reproductive organs [30], and plasma ANG-2 levels are higher in non-pregnant women than in men [31].”
BackgroundFetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
Rasul, S., Wagner, L., & Kautzky‐Willer, A. (2012) · Endocrine · doi:10.1007/s12020-012-9754-4 · Cited by 39
“In addition, adipose tissue is a storage place of pro-inflammatory mediators such as interleukin-6 (IL-6), plasminogen activator inhibitor-1 (PAI-1), and C-reactive protein (CRP) that are participating directly in the patho- genesis of vascular damage, insulin resistance, and obesity- related atherogenesis.”
BackgroundInfluentialCustodio, A., Barriuso, J., de Castro, J., Martínez-Marín, V., Moreno, V., Rodríguez-Salas, N., & Feliú, J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.02.004 · Cited by 40
Song, M., Wu, K., Meyerhardt, J. A., Yilmaz, Ö. H., Wang, M., Ogino, S., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky077 · Cited by 40
“In contrast, food sources of plant fats (eg, oils and nuts) may reduce circulating insulin and markers of inflammation and glycemic control (30,31), all of which may affect CRC progression (5,32,33).”
BackgroundTargeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Khan, K. H., Cunningham, D., & Chau, I. (2016) · Current Drug Targets · doi:10.2174/1389450116666150325231555 · Cited by 34
“Ang-2 can be over-expressed in multiple tumour types, including CRC; high Ang-2 levels have also been shown to promote metastatic growth and poorer survival outcomes in CRC [44-46].”
BackgroundMolecular description of ANGPT2 associated colorectal carcinoma
Jary, M., Hasanova, R., Vienot, A., Asgarov, K., Loyon, R., Tirole, C., Bouard, A., Orillard, É., Klajer, É., Kim, S. C. H., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32993 · Cited by 35
Terlikowska, K. M., Dobrzycka, B., Terlikowski, R., Sienkiewicz, A., Kinalski, M., & Terlikowski, S. J. (2020) · BMC Cancer · doi:10.1186/s12885-020-07415-x · Cited by 32
Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer
Chong, D. Q., Mehta, R. S., Song, M., Kedrin, D., Meyerhardt, J. A., Ng, K., Wu, K., Fuchs, C. S., Giovannucci, E. L., Ogino, S., et al. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0175 · Cited by 29
“The only prospective study showed that adiponectin (measured at time of diagnosis) was not predictive of colorectal cancer survival (26).”
BackgroundTeoh, S. L., & Das, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5357-7 · Cited by 33
The Ketogenic Diet in Colorectal Cancer: A Means to an End
Tamraz, M., Ghossaini, N. A., & Temraz, S. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043683 · Cited by 35
“Thus, a KD which is rich in fat specifically from plant origin and low in carbohydrates has insulin sensitizing capability which could affect CRC progression [80,81].”
BackgroundShah, M. S., Fogelman, D. R., Raghav, K. P. S., Heymach, J. V., Tran, H. T., Jiang, Z., Kopetz, S., & Daniel, C. R. (2015) · Cancer · doi:10.1002/cncr.29440 · Cited by 27
“In a clinical cohort of 344 patients with varying stages of CRC, Volkova et al reported that serum markers and anthropometric measures of obesity were highly correlated, but only patients with high serum levels of circulating inflammatory markers had significantly reduced survival, leading the authors to similarly con…”
BackgroundGolledge, J., Clancy, P., Yeap, B. B., Hankey, G. J., & Norman, P. E. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.120 · Cited by 29
“Although increased circulating concentrations of Angpt2 have been associated with various types of cancers and their prognosis, the association of Angpt2 with vascular diseases has received relatively little attention [9–19].”
BackgroundSchuldt, E., Lieb, W., Dörr, M., Lerch, M. M., Völzke, H., Nauck, M. A., & Friedrich, N. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.003 · Cited by 25
Hua, X., Kratz, M., Malen, R. C., Dai, J. Y., Lindström, S., Zheng, Y., & Newcomb, P. A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01458-y · Cited by 26
Kim, S. C. H., Dobi, E., Jary, M., Monnien, F., Curtit, E., Nguyen, T., Lakkis, Z., Heyd, B., Fratté, S., Cléau, D., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-611 · Cited by 24
“First, angiopoietin-2 expression was shown to be correlated with colorectal cancer stages and progression [31].”
BackgroundChiu, C., Ho, C., Hung, C., Chao, C., Lai, C., Chen, C., Liao, K., Wang, J., Wu, Y.-C., Shi, H., et al. (2021) · Cancers · doi:10.3390/cancers13143592 · Cited by 25
“Physical inactivity deteriorates adipose tissue accumulation, and the subsequent activation of inflammatory cytokines could promote CRC development [59].”
BackgroundJary, M., Vernerey, D., Lecomte, T., Dobi, E., Ghiringhelli, F., Monnien, F., Godet, Y., Kim, S. C. H., Bouché, O., Fratté, S., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1059 · Cited by 25
“Moreover, Ang-2 expression was shown to be correlated with colorectal cancer stages and progression (44, 45).”
BackgroundMining Cancer-Specific Disease Comorbidities from a Large Observational Health Database
Chen, Y., & Xu, R. (2014) · Cancer Informatics · doi:10.4137/cin.s13893 · Cited by 22
“42,43 In addition, osteoporosis tends to occur among elderly cancer patients (Fig.”
Miyagawa, Y., Yanai, A., Yanagawa, T., Inatome, J., Egawa, C., Nishimukai, A., Takamoto, K., Morimoto, T., Kikawa, Y., Suwa, H., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27423 · Cited by 21
Network Analysis of Human Disease Comorbidity Patterns Based on Large-Scale Data Mining
Chen, Y., & Xu, R. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-08171-7_22 · Cited by 20
“development of colon cancer (Schoen et al., 1999; Komninou et al., 2003; Volkova et al., 2011).”
Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
Roškar, L., Roškar, I., Rižner, T. L., & Smrkolj, Š. (2021) · Biomolecules · doi:10.3390/biom12010007 · Cited by 22
“Furthermore, it has been proposed by various authors that Ang-2 is also a marker of obesity [50,51] and is possibly associated with the development of obesityrelated diseases, such as EC.”
BackgroundDesidero, T. D., Orlandi, P., Fioravanti, A., Alì, G., Cremolini, C., Loupakis, F., Gentile, D., Banchi, M., Cucchiara, F., Antoniotti, C., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.001 · Cited by 17
Changes and significance of serum angiopoietin-2 levels in patients with coronary heart disease
Wang, X., Yong, H., Mi, L., Bai, Y., Guo, L., Gao, W. Q., Cui, M., & Zhang, Y. (2012) · Biomarkers · doi:10.3109/1354750x.2012.727028 · Cited by 16
“2011), and colorectal cancer (Volkova et al. 2011) found that the peripheral blood Ang-2 and hs-CRP levels were significantly higher than those in the control group, and both levels were significantly positively correlated.”
BackgroundBecerra‐Tomás, N., Markozannes, G., Cariolou, M., Balducci, K., Vieira, R. D. C. P. A., Kiss, S., Aune, D., Greenwood, D. C., Dossus, L., Copson, E., et al. (2024) · International Journal of Cancer · doi:10.1002/ijc.34905 · Cited by 16
Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis
Xuan, Z., Zhang, S., Yuan, S., Wang, W., & Yu, J. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-0992-4 · Cited by 22
“While the role of Ang-2 in angiogenesis and tumor therapy is well-established, it is also found that Ang-2 expression is associated with prognosis of various tumors, such as chronic lymphocytic leukemia [16], hepatocellular carcinoma [17], colorectal cancer [18], and melanoma [19].”
BackgroundMooi, J. K., Chionh, F. J. M., Savas, P. S., Duarte, J. D. G., Chong, G., Brown, S. C., Wong, R., Price, T. J., Wann, A., Skrinos, E., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2714 · Cited by 16
Zhang, Z., Zhou, J., Zhang, Y., Zhu, D., Li, D., & Zhao, H. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9532-9 · Cited by 17
Obesity, Diabetes and Metabolic Syndrome Impact on Tumor Angiogenesis
Incio, J., & Soares, R. (2013) · CRC Press eBooks · doi:10.1201/b14842-13 · Cited by 13
Banck-Petersen, A., Olsen, C. K., Djurhuus, S. S., Herrstedt, A., Thorsen-Streit, S., Ried‐Larsen, M., Østerlind, K., Osterkamp, J. T. F., Krarup, P., Vistisen, K. K., et al. (2018) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2018.01.008 · Cited by 10
Ahmadirad, H., Teymoori, F., Mokhtari, E., Jahromi, M. K., Norouzzadeh, M., Tavakkoli, S., Shahrokhtabar, T., Farhadnejad, H., & Mirmiran, P. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1205481 · Cited by 12
Harris, H. J., Łaniewski, P., Cui, H., Roe, D. J., Chase, D. M., & Herbst‐Kralovetz, M. M. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00219-6 · Cited by 10
Maroto‐Izquierdo, S., Bautista, I. J., Pérez-Guerrero, A., Redondo‐Delgado, P., Jauregui-Fajardo, I., Simó, V., & Aldecoa, C. (2025) · Healthcare · doi:10.3390/healthcare13101119 · Cited by 12
“This assessment allows for an understanding of the patients’ functional capacity [20–26], which is crucial in reducing disease recurrence and mortality [27,28].”
Hua, X., Dai, J. Y., Lindström, S., Harrison, T. A., Lin, Y., Alberts, S. R., Alwers, E., Berndt, S. I., Brenner, H., Buchanan, D. D., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1848 · Cited by 10
“Some studies observed that circulating CRP concentration measured before surgery was not statistically significantly associated with survival after multivariable adjustment (7, 8).”
BackgroundGuercio, B. J., Zhang, S., Ou, F., Venook, A. P., Niedzwiecki, D., Lenz, H., Innocenti, F., Pollak, M., Nixon, A. B., Mullen, B. C., et al. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkaa074 · Cited by 11
“One prospective study found high adiponectin to be associated with greater CRC-specific and overall mortality (11), whereas another study found no association (53).”
Du, Z., Tang, C., Li, L., Kang, L., Jin, Z. Y., Jin, L., Wang, C., & Su, C. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.37675 · Cited by 9
“Angpt2 is known to be involved in CRC progression and survival [20].”
BackgroundSinicrope, F. A., Shi, Q., Smyrk, T. C., Goldberg, R. M., Cohen, S. J., Gill, S., Kahlenberg, M. S., Nair, S., Shield, A. F., Jahagirdar, B., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab070 · Cited by 10
“Adiponectin at diagnosis of CRC was also not prognostic in a prospective study in 344 consecutive cases (10).”
BackgroundLumachi, F., Basso, S. M. M., Santeufemia, D. A., Ermani, M., Re, G. L., & Chiara, G. B. (2014) · PubMed · Cited by 9
Mori, S., Kita, J., Kato, M., Shimoda, M., & Kubota, K. (2014) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2014.02.015 · Cited by 8
The Angiopoietin-2/Angiopoietin-1 ratio increases early in burn patients and predicts mortality
Heuberger, D. M., Wendel‐Garcia, P. D., Sazpinar, O., Müller, M. M., Klein, H. J., Kim, B., Andermatt, R., Erlebach, R., Schuepbach, R. A., Buehler, P. K., et al. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156266 · Cited by 8
Impact of non-alcoholic fatty liver disease and smoking on colorectal polyps
Chen, Q., Zhou, X., Fang, D., Sun, Y., Zhao, Q., Huang, J., Jin, Y., & Wu, J.-S. (2017) · Oncotarget · doi:10.18632/oncotarget.20462 · Cited by 7
“These inflammatory biomarkers inhibit cell apoptosis and promote cell proliferation, angiogenesis and metastasis, which may partly explain the formation of colorectal polyps in men with NAFLD and smoking habit [16, 29, 30].”
BackgroundImpact of body mass index on overall survival after surgery for colorectal cancer
Park, S. W., Lee, D., Park, J. W., Ryoo, S., Shin, R., Jeong, S., & Park, K. J. (2016) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.16015 · Cited by 6
“3%, 2013년 기준)이며, 암사망률 4위(전체 암 사망자 중 11%)로 전 세계적인 발생률, 사망률과 비슷한 양상을 보인다[1-3].”
Güveli̇, M. E., Duranyıldız, D., Karadeniz, A. N., Bilgin, E., Serilmez, M., Oğuz, H., & Yasasever, V. (2016) · Tumor Biology · doi:10.1007/s13277-015-4777-0 · Cited by 5
Immune Response and Oxidative Stress in Obesity-Induced Cancer
Jaiswara, P. K., Sonker, P., & Kumar, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_6 · Cited by 3
Prediction of Outcome of Sepsis at Surgical ICU: A Prospective Multi-Center Prospective Study
Salem, A. M. (2019) · Journal of Anesthesia & Intensive Care Medicine · doi:10.19080/jaicm.2019.08.555743 · Cited by 2
“Human CRP was measured with the Enzyme Linked Immunoassay (ELISA) kit () by quantitative sandwich enzyme immunoassay technique [17].”
MethodAlkassas, A., Fouda, M. H., Fassini, G. M., & Sanhoury, M. I. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00383-0 · Cited by 2
“, San Francisco, USA) by quantitative sandwich enzyme immunoassay technique [23].”
MethodBakour, N., Duggan, C., & Annett, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008462 · Cited by 1
Khashaba, M. A., Abdelal, I. F., Abdelrahman, S. M., & Rahman, M. H. A. (2022) · Egyptian Journal of Anaesthesia · doi:10.1080/11101849.2022.2125249 · Cited by 1
“…Inc., San Francisco, USA) by quantitative sand-wich enzyme immunoassay technique [20]. b. Human CRP level using ELISA kit (catalog no. ab99995, Abcam Inc., San Francisco, USA) by quantitative sandwich enzyme immunoassay technique [21]. c. Human prespesin (PSP) level using ELISA kit (catalog no.”
MethodMaroto‐Izquierdo, S., Bautista, I. J., Menéndez, H., Pinto-Fraga, J., Simó, V., & Aldecoa, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4062284/v1 · Cited by 1
Angiopoietin-1 and -2 in Infectious Diseases associated with Endothelial Cell Dysfunction
Page, A. V., & Liles, W. C. (2012) · TSpace (University of Toronto)
Dancey, G. J. (2011) · UCL Discovery (University College London)
The link between obesity, colorectal cancer progression and tumour angiogenesis
Volkova, E. (2011) · Otago University Research Archive (University of Otago)
Self-citationHorsley, L. (2015) · Research Explorer (The University of Manchester)
Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a
Xuan, Z., Zhang, S., Yuan, S., Wang, W., & Yu, J. (2016)
Al-Kholy, A. F., Salem, A., & Hagras, M. M. (2017) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2017.8243
Mooi, J. K., Chionh, F. J. M., Savas, P. S., Duarte, J. D. G., Chong, G., Brown, S., Wong, R., Price, T. J., Wann, A., Skrinos, E., et al. (2023) · doi:10.1158/1078-0432.c.6531279.v1
Mooi, J. K., Chionh, F. J. M., Savas, P. S., Duarte, J. D. G., Chong, G., Brown, S., Wong, R., Price, T. J., Wann, A., Skrinos, E., et al. (2023) · doi:10.1158/1078-0432.c.6531279
Identification of new biomarkers for colorectal cancers
Hasanova, R. (2019) · theses.fr (ABES) · doi:10.70675/38dbe0adza892z41d3za889zbee31c0eb152
Strojny, Z., Kanikowska, D., Kanikowska, A., Tomczak, Z., Sikora, W., Sato, M., Strojny, M., Żuraszek-Szymańska, J., Deja, T., Bręborowicz, A., et al. (2026) · Cytokine · doi:10.1016/j.cyto.2026.157190
Metadata
- Authors
- Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J.
- Affiliations
- University of Otago (NZ)
- Christchurch Hospital (NZ)
- Corresponding author
- Currie, M J
- Venue
- British Journal of Cancer
- Published
- 2010-11-16
- Volume
- 104
- Issue
- 1
- Pages
- 51-59
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3039823
- OpenAlex
- W1987497125
- Cited by
- 78
- References
- 55
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 8 · 2012: 6
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tertiary Education Commission
- University of Otago
- Cancer Society of New Zealand
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- colorectal cancer, angiopoietin-2, C-reactive protein, obesity, insulin resistance, inflammation, angiogenesis, VEGF-A, insulin-like growth factor I, adiponectin, cancer survival, prognostic factors, tumor stage, obesity-associated inflammation
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, C-Peptide, C-Reactive Protein, Enzyme-Linked Immunosorbent Assay, Female, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Middle Aged, Obesity, Prospective Studies, Colorectal Neoplasms, Biomarkers, Body Mass Index, Survival Rate, Treatment Outcome, Vascular Endothelial Growth Factor A, Angiopoietin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.